GENE ONLINE|News &
Opinion
Blog

LATEST
China Series C Funding
China’s Metabolic Drugmaker Scores $70M Series C to Accelerate Drug Trials
2021-10-13
M&A
Supernus Invests $400 Million to Acquire New Parkinson’s Assets from Adamas
2021-10-12
Special Digital Therapeutics
Are Digital Therapeutics the Next Generation of Medical Products?
2021-10-12
M&A Pain Management
Pacira Acquires Flexion for $425 Million to Expand Non-Opioid Painkiller Portfolio
2021-10-12
Licensing Gene Therapy
Takeda Embarks On a Billion-Dollar Gene Therapy Deal with Selecta Biosciences
2021-10-08
Special
Landmark CRISPR Trial Shows Promise Against Fighting Blindness, but Is It a Cure?
2021-10-08
Trials & Approvals Brukinsa
BeiGene Gets Its First Regulatory Nod in Australia for Rare Lymphoma
2021-10-08
Special Biofuel
From Food to Fuel, Are Algae the Future of Biotech?
2021-10-08
Asia-Pacific CDMO
Samsung Biologics Inks CDMO Deal with Enzolytics on HIV and COVID-19 Antibodies
2021-10-08
Special Targeted Protein Degrader
Expanding Deals and Investments Underscore Burgeoning Market of Targeted Protein Degradation
2021-10-07
Licensing Gene Therapy
Voyager Therapeutics’ Novel AAV Capsid Tech for Gene Therapy Attracts Pfizer’s Investment
2021-10-07
BARDA Exercises $23.8 Million to Support Phase 3 Trial of Vedanta’s Encouraging Microbiome Therapy
2021-10-07
Takeda Hits the Brakes on Narcolepsy Drug Trials
2021-10-07
China CSCO
2021 CSCO Highlights: JW Therapeutics, Innovent, Ambrx, HUTCHMED Release Latest Data on Cancer Drugs
2021-10-07
Special Malaria
WHO Approves Widespread Use of World’s First Malaria Vaccine
2021-10-06
1 … 114 115 116 117 118 … 219
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top